Diabetic retinopathy and mortality in type 2 diabetic patients;Relación entre la presencia de retinopatía diabética y la mortalidad en pacientes con diabetes tipo 2

Medicina Clinica

Volumn 126, Issue 18, 2006, Pages 686-689

  Gimeno Orna, José Antonio ^a,b   Castro Alonso, Francisco J ^a   Sánchez Vañó, Raquel ^a   Latre Rebled, Beatriz ^a   Lou Arnal, Luis M ^a   Molinero Herguedas, Edmundo ^a  

^a Hospital de Alcañiz Alcañiz   (Spain)

^b NONE   (Spain)

Author keywords

Diabetic retinopathy; Mortality; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE DURATION; FEMALE; FOLLOW UP; HUMAN; INSULIN TREATMENT; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; PROLIFERATIVE RETINOPATHY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; PROTEINURIA; RISK FACTOR;

EID: 33745755609     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13088771     Document Type: Article

References (24)

1. Morrish NJ, Wang SL, Stevens LK, Fuller JH, Keen H, and the WHO Multinational Study Group. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44 Suppl 2:S14-21.
2. Gimeno-Orna JA, Boned-Juliani B, Lou-Arnal LM, Castro-Alonso FJ. Mortalidad en una cohorte de pacientes con diabetes tipo 2 del área de Alcañiz. An Med Interna. 2002;19:336-40.
3. Porta M, Bandello F. Retinopatía diabetica. Diabetologia. 2002;45:1617-34.
4. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol. 1974;78:58-67.
5. Hanis CL, Chu H, Lawson K, Hewett-Emmett D, Barton SA, Schull WJ, et al. Mortality of Mexican Americans with NIDDM. Retinopathy and other predictors in Starr County, Texas. Diabetes Care. 1993;16:82-9.
6. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol. 1999;117:1487-95.
7. Fuller JH, Stevens LK, Wang SL, and the WHO Multinational Study Group. Risk factors for cardiovascular mortality and morbidity: the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44 Suppl 2:S54-64.
8. Parvanova A, Iliev I, Filipponi M, Dimitrov BD, Vedovato M, Tiengo A, et al. Insulin resistance and proliferative retinopathy: a cross-sectional, case control study in 115 patients with type 2 diabetes. J Clin Endocrinol Metab. 2004;89:4371-6.
9. World Health Organization Study Group on Diabetes Mellitus. Technical report series 727. Geneva: WHO; 1985.
10. Davis MD, Hiller R, Magli YL, Podgor MJ, Ederer F, Harris WA, et al. Prognosis for life in patients with diabetes: relation to severity of retinopathy. Trans Am Ophthalmol Soc. 1979;77:144-70.
11. Sharma NH, Archer DB, Hadden DR. Morbidity and mortality in patients with diabetic retinopathy. Eye. 1980;100:83-9.
12. Wong TY, Klein R, Nieto J, Klein BE, Sharrett R, Meuer SM, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality. Ophthalmology. 2003;110:933-40.
13. Klein R, Moss SE, Klein BE, DeMets DL. Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med. 1989;149:266-72.
14. Neil A, Hawkins M, Potok M, Thorogood M, Cohen D, Mann J. A prospective population-based study of microalbuminuria as a predictor of mortality in NIDDM. Diabetes Care. 1993;16:996-1003.
15. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-86.
16. Warram JH, Manson JE, Krolewski AS. Glycosylated hemoglobin and the risk of retinopathy in insulin-dependent diabetes mellitus. N Engl J Med. 1995;332:1305-6.
17. The Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long term complications: the perspective of the Diabetes Control and Complications Trial. Diabetes. 1996;45:1289-98.
18. Strattom IM, Adler AI, Neil HAW, Mattews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405-12.
19. Wei M, Gaskill SP, Haffner SM, Stern MP. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. Diabetes Care. 1998;21:1167-72.
20. Miettinen H, Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Retinopathy predicts coronary heart disease events in NIDDM patients. Diabetes Care. 1996;19:1445-8.
21. Deckert T, Feldt-Rasmussen B, Borch-Johnsen K, Jensen T, Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia. 1989;32:219-26.
22. Knudsen ST, Bek T, Poulsen PL, Hove MN, Rehling M, Mogensen CE. Macular edema reflects generalized vascular hyperpermeability in type 2 diabetic patients with retinopathy. Diabetes Care. 2002;25:2328-34.
23. Rema M, Mohan V, Deepa R, Ravikumar R. Association of carotid intima-media thickness and arterial stiffness with diabetic retinopathy. The Chennai Urban Rural Rural Epidemiological Study (CURES 2). Diabetes Care. 2004;27:1962-7.
24. Real JT, Valls M, Ascaso P, Basanta ML, Viguer A, Ascaso JF, et al. Factores de riesgo asociados a la hospitalización en pacientes diabéticos con úlceras en los pies. Med Clin (Barc). 2001;117:641-4.